<DOC>
	<DOCNO>NCT02539498</DOCNO>
	<brief_summary>Bone lesion frequent primary hyperparathyroidism ( PHPT ) . Conventional measurement Dual-Energy X-ray Absorptiometry provide enough information bone impact excessive parathyroid hormone ( PTH ) secretion . High-Resolution peripheral Quantitative Computed Tomography ( HR-pQCT ) assess separately cortical trabecular bone sit well geometric characteristic peripheral skeleton . In postmenopausal woman , HR-pQCT show decreased microarchitectural parameter associate reduced bone strength independently BMD . The purpose study characterize impact PHPT cortical trabecular bone measure HR-pQCT postmenopausal woman PHPT follow one year , comparison control postmenopausal woman .</brief_summary>
	<brief_title>Bone Architectural Parameters Postmenopausal Women Affected With Primary Hyperparathyroidism</brief_title>
	<detailed_description>Principal objective : To characterize impact PHPT cortical trabecular bone measure HR-pQCT postmenopausal woman PHPT follow one year , comparison control postmenopausal woman . Secondary Objectives : 1 ) To compare change bone micro-architecture PHPT woman without surgery control 2 ) To determine change micro-architecture related severity PTH secretion change surgery 3 ) evaluate association clinical biological factor quantitative bone micro-architectural index change . Principal evaluation criterion : Cortical thickness Secondary evaluation criterion : Quantitative parameter measure HR-pQCT : trabecular microarchitecture ( trabecular bone volume , number , separation , thickness heterogeneity trabecula ) , cortical microarchitecture ( total surface , polar moment inertia ) , volumetric density total , cortical trabecular bone . Biological parameter : PTH , serum calcium phosphorus , 25 ( OH ) D , 1,25 ( OH ) 2D , biomarkers bone remodelling , urinary calcium . BMD measure DXA . Clinical factor risk bone loss . Type study : Pathophysiological , multicentric , comparative study , prospective follow-up one year postmenopausal caucasian woman affect PHPT ( case ) non affect PHPT ( control ) . Each control match age , date menopause , height weight , PHPT woman . Study design : assessment bone mineral metabolism , DXA measurement index HR-pQCT inclusion . Those test renew one year surgery PHPT patient one year baseline without surgery control . Number patient need : 120 postmenopausal woman , 60 case 60 control Total duration study : 56 month . Inclusion period : 42 month Inclusion criterion principal non-inclusion criterion : Patients : caucasian woman , menopaused least one year , age less 81 year , affect symptomatic asymptomatic PHPT without disease medication interfere bone mineral metabolism . Control population : caucasian woman , menopaused least one year , age less 81 year , without PHPT , diseases medication interfere bone mineral metabolism .</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<criteria>Patients : caucasian woman , menopaused least one year , age less 81 year , affect symptomatic asymptomatic PHPT Control population : caucasian woman , menopaused least one year , age less 81 year , without PHPT diseases medication interfere bone mineral metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Primary Hyperparathyroidism</keyword>
	<keyword>Parathyroid Hormone</keyword>
	<keyword>High-Resolution peripheral Quantitative Computed Tomography</keyword>
	<keyword>Bone densitometry</keyword>
	<keyword>Bone microarchitecture</keyword>
</DOC>